A new pancreatic cancer therapy targets sugar molecules on cell surfaces, offering hope where traditional immunotherapies ...

About 1 million people in the U.S. live with multiple sclerosis, a chronic autoimmune disease that inflames the nervous ...

Researchers at UCLA have developed a powerful new weapon in the battle against kidney cancer. Instead of relying on treatments tailored to each patient, this innovation uses specially engineered ...

To make the therapy safer and more adaptable, UChicago researchers developed a new “split” system called GA1CAR. This uses ...

So far, immune cells that have been engineered to kill cancers, known as CAR T-cells, haven’t worked well against solid cancers - but a study in mice suggests that could soon change ...

Pancreatic cancer, also known as pancreatic ductal adenocarcinoma, is one of the most aggressive types of cancer. Despite ...

Durable survival and deep, lasting remissions in checkpoint-refractory, heavily pretreated cancers with median OS of ~23 months with agenT-797 plus anti-PD-1Evidence of immune activation and ...

Researchers from the Massachusetts Institute of Technology (MIT) and Harvard Medical School have found a novel way to ...

Researchers at Moffitt Cancer Center have developed a novel biomaterial-based system that induces the formation of tertiary ...

Metastasis remains the deadliest cancer complication, driven by circulating tumor cells (CTCs) that evade immune defenses in ...

An international research team focused on aging reports that urolithin A at 1,000 mg per day shifted human immune profiles ...